|
58
|
231
|
7nhtA |
Akirin2 bound human proteasome |
|
68
|
242
|
7nhtG |
Akirin2 bound human proteasome |
|
76
|
248
|
7nhtB |
Akirin2 bound human proteasome |
|
58
|
241
|
7nhtD |
Akirin2 bound human proteasome |
|
61
|
236
|
7nhtE |
Akirin2 bound human proteasome |
|
66
|
237
|
7nhtC |
Akirin2 bound human proteasome |
|
63
|
242
|
7nhtF |
Akirin2 bound human proteasome |
|
68
|
235
|
7lxvC |
Structure of human 20s proteasome with bound mpi-5 |
|
58
|
242
|
7lxuG |
Structure of plasmodium falciparum 20s proteasome with bound mpi-5 |
|
60
|
244
|
7lxvG |
Structure of human 20s proteasome with bound mpi-5 |
|
50
|
252
|
7lxtA |
Structure of plasmodium falciparum 20s proteasome with bound bortezomib |
|
53
|
227
|
7lxtB |
Structure of plasmodium falciparum 20s proteasome with bound bortezomib |
|
66
|
243
|
7lxvB |
Structure of human 20s proteasome with bound mpi-5 |
|
60
|
242
|
7lxtC |
Structure of plasmodium falciparum 20s proteasome with bound bortezomib |
|
50
|
233
|
7lxuD |
Structure of plasmodium falciparum 20s proteasome with bound mpi-5 |
|
61
|
242
|
7lxuC |
Structure of plasmodium falciparum 20s proteasome with bound mpi-5 |
|
60
|
236
|
7lxvD |
Structure of human 20s proteasome with bound mpi-5 |
|
59
|
229
|
7lxuB |
Structure of plasmodium falciparum 20s proteasome with bound mpi-5 |
|
45
|
233
|
7lxtD |
Structure of plasmodium falciparum 20s proteasome with bound bortezomib |
|
66
|
239
|
7lxvF |
Structure of human 20s proteasome with bound mpi-5 |
|
61
|
229
|
7lxvA |
Structure of human 20s proteasome with bound mpi-5 |
|
64
|
251
|
7lxuA |
Structure of plasmodium falciparum 20s proteasome with bound mpi-5 |
|
61
|
236
|
7lxvE |
Structure of human 20s proteasome with bound mpi-5 |
|
57
|
235
|
7lxuF |
Structure of plasmodium falciparum 20s proteasome with bound mpi-5 |
|
50
|
243
|
7lxuE |
Structure of plasmodium falciparum 20s proteasome with bound mpi-5 |
|
51
|
240
|
7lxtE |
Structure of plasmodium falciparum 20s proteasome with bound bortezomib |
|
52
|
235
|
7lxtF |
Structure of plasmodium falciparum 20s proteasome with bound bortezomib |
|
52
|
240
|
7lxtG |
Structure of plasmodium falciparum 20s proteasome with bound bortezomib |
|
45
|
238
|
7v5gO |
20s+monoub-cyclinb1-nt (s1) |
|
40
|
233
|
7v5mF |
20s+monoub-cyclinb1-nt (s2) |
|
51
|
248
|
7v5gQ |
20s+monoub-cyclinb1-nt (s1) |
|
49
|
228
|
7v5gP |
20s+monoub-cyclinb1-nt (s1) |
|
46
|
229
|
7v5mB |
20s+monoub-cyclinb1-nt (s2) |
|
51
|
247
|
7v5mC |
20s+monoub-cyclinb1-nt (s2) |
|
47
|
239
|
7v5gU |
20s+monoub-cyclinb1-nt (s1) |
|
51
|
233
|
7v5mE |
20s+monoub-cyclinb1-nt (s2) |
|
49
|
233
|
7v5gT |
20s+monoub-cyclinb1-nt (s1) |
|
46
|
232
|
7v5mD |
20s+monoub-cyclinb1-nt (s2) |
|
48
|
240
|
7v5mA |
20s+monoub-cyclinb1-nt (s2) |
|
50
|
239
|
7v5mG |
20s+monoub-cyclinb1-nt (s2) |
|
50
|
232
|
7v5gR |
20s+monoub-cyclinb1-nt (s1) |
|
51
|
233
|
7v5gS |
20s+monoub-cyclinb1-nt (s1) |
|
66
|
229
|
7aweB |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
|
75
|
247
|
7aweC |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
|
65
|
242
|
7aweG |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
|
68
|
240
|
7aweA |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
|
69
|
234
|
7aweD |
Human immunoproteasome 20s particle in complex with [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid |
|
64
|
231
|
6zp6E |
Yeast 20s proteasome in complex with glidobactin-like natural product hb334 |
|
65
|
241
|
6zp6G |
Yeast 20s proteasome in complex with glidobactin-like natural product hb334 |
|
63
|
241
|
6zp8G |
Yeast 20s proteasome in complex with glidobactin-like natural product hb335 |
